Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 8 , ISSUE 1 ( January-March, 2016 ) > List of Articles


Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years

Marzieh Akbarzadeh, Tahereh Naderi, Mohammad H Dabbaghmaneh, Hamidreza Tabatabaee

Citation Information : Akbarzadeh M, Naderi T, Dabbaghmaneh MH, Tabatabaee H. Comparison of Levels of Androgenic Hormones in various Phenotypes of Polycystic Ovarian Syndrome in High School Girls aging 14 to 18 Years. J South Asian Feder Obs Gynae 2016; 8 (1):33-39.

DOI: 10.5005/jp-journals-10006-1382

Published Online: 01-06-2013

Copyright Statement:  Copyright © 2016; The Author(s).


PDF Share
  1. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod 2012;27(5):1481-1488.
  2. A survey of metabolic syndrome in first-degree relatives (fathers) of patients with polycystic ovarian syndrome, JEMDSA 2013;18(2):98-103.
  3. Phenotype and metabolic disorders in polycystic ovary syndrome. International Scholarly Research Network. ISRN Endocrinol 2012;569862. doi: 10.5402/2012/569862.
  4. Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome. Clin Exp Reprod Med. 2013;40(2):100-105.
  5. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod 2009;24(9): 2286-2292.
  6. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab 2014 May;18(3):317-324.
  7. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011;62(3):238-242.
  8. The Association of obesity and hyperandrogenemia during the pubertal transition in girls. J Clin Endocrin Metabolism 2005;91(5): 1714-1722.
  9. Progesterone inhibition of the hypothalamic gonadotropin—releasing hormone pulse generator: evidence for varied effects in hyperandrogenic adoplescent girls. J Clin Endocrinol Metab 2005;90(5):2810-2815.
  10. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009; 92(2):626-634.
  11. Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92(3):787-796.
  12. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.
  13. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 2008 Aug;23(8):1924-1931.
  14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod 2012 Feb;27(2):541-549.
  15. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 2007;67(5):735-742.
  16. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol Gynecol Endocrinol 2007; 23(10):604-609.
  17. Risk of metabolic complications in the new PCOS phenotype based on the Rotterdam criteria. Fertil Steril 2007;88(5):1389-1395.
  18. Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. Endocrine 2011 Jun;39(3):272-277.
  19. Polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res 2004;62(6): 278-282.
  20. Clinical assessment of body hair growth in women. Endocr Rev 2000;21(4):347-362.
  21. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977 Sep;97(3):247-257.
  22. Gynecology. 13th ed. Philadelphia: Waverly; 2007. p. 149-172.
  23. Prevalence of polycystic ovaries in women with idiopathic hirsutism. Br Med J (Clin Res Ed). 1986;9;293(6543):355-359.
  24. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol 2010;149(1):68-71.
  25. Trasvaginal ultasound imaging, histopatology and endocrinopathy in patient with polycystic ovarian syndrome. Hum Reprod 1994;9(7):1231-1236.
  26. Polycystic ovary syndrome. N Engl J Med 2005 Mar 24;352(12):1223-1236.
  27. Endocrin Disorder. Novak's Gynecology. In: Berek JS, editor. Lippincott Williams & Wilkins; 2002. p. 871-917.
  28. Recovery of hormon secretion after chronic gonadotropin-releasing hormon agonist administration in women with PCO disease. J Clin Endocrinol Metab 1989;68(6):1111-1117.
  29. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab, 1983;57(2):393-397.
  30. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormon, androgens and insulin. Fertil Steril, 2000;74(1):49-58.
  31. How possible is the prevention of PCO develope in adolescent patients with early onset of hyperandrogenism. Endocrinol Invest 1998;21(9):613-617.
  32. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2014 Sep;81(3):426-431.
  33. [Adrenal androgen participation in the polycystic ovary syndrome]. Rev Bras Ginecol Obstet 2010 Nov;32(11):541-548.
  34. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertility and sterility 2002;77(6):1095-1105.
  35. Novak ‘s gynecology, 12th ed, Philadelphia, Lippincott Williams & Wilkins; 2002. p. 158-160.
  36. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 2006 Oct;91(10):3922-3927.
  37. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril 2010;94(6):2197-2201.
  38. The prevalence of the polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust NZ J Obstet Gynaecol 1994;34(1):67-72.
  39. Clinical characteristics, laboratory and ultrasound polycystic ovary syndrome in Kerman. Journal of Endocrinology and Metabolism University of Medical Sciences and Health Services Beheshti 2004;6(2):153-161. (persion)
  40. Polycystic ovarian syndrome: clinical and laboratory evaluation. Sao Paulo Med J 1996;114(4):1222-1225.
  41. Endocrine features of polycystic ovary syndrome in an random population sample of 14-16 years old adolescents. Hum reprod 1999;14(9):2223-2229.
  42. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010;93(6):1938-1941.
  43. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006 Apr;114(4): 175-181.
  44. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 2005 May;90(5):2571-2579.
  45. Use of insulin sensitizers in polycystic ovarian syndrome. Curr Opin Investig Drugs 2005 Oct;6(10):1012-1022.
  46. Prevalence of metabolic disorders among family member of patiens with polycystic ovary syndrome. The Journal of Review Medical Chil 2001;129(7):707-712.
  47. Hypernisulinemia is common in family members of women with polcystic ovary syndrome. Fertil Steril 1996 Dec;66(6):942-947.
  48. Glucose intolerance, insulin resistance and hyprandrogenemia in first degree relatives of woman with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88(5):2031-2036.
  49. Insulin resistance in first-degree relatives of the patients with polycystic ovarian syndrome. IJDO 2013;5(4):163-170.
  50. Metabolic syndrome and Ischemic heart disease in elderly men and women. Am J Epidemiol 2001 Mar 1;153(5):481-489.
  51. Prevalence of metabolic syndrome related disorder in a large adult population in Turkey. BMC Public Health 2006 Apr 10;6:92.
  52. Premenarcheal endocrine change in relation to age at menarche. Clin Endocrinol (Oxf) 1985;22(6):753-760.
  53. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol 2011 Nov; 9:144.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.